vTv Therapeutics Inc.
VTVT
$25.24
$1.747.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 117.74% | 19.31% | 6.83% | -431.06% | 14.16% |
| Gross Profit | -117.74% | -19.31% | -71.62% | 432.65% | -14.16% |
| SG&A Expenses | 12.10% | -2.64% | -7.67% | 4.13% | 29.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.45% | 7.91% | -1.87% | 4.29% | 21.20% |
| Operating Income | -64.45% | -7.91% | -15.57% | -3.93% | -21.20% |
| Income Before Tax | -77.14% | -15.15% | -5.03% | 0.09% | 31.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -77.14% | -15.15% | -3.29% | 0.09% | 31.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 55.82% | 8.54% | -2.51% | -16.61% | -43.96% |
| Net Income | -81.85% | -16.72% | -4.67% | -4.49% | 28.12% |
| EBIT | -64.45% | -7.91% | -15.57% | -3.93% | -21.20% |
| EBITDA | -64.98% | -8.22% | -15.86% | -3.97% | -21.29% |
| EPS Basic | 20.03% | -13.48% | -1.82% | 66.91% | 72.53% |
| Normalized Basic EPS | 18.29% | -14.78% | -5.51% | 65.77% | 71.29% |
| EPS Diluted | 20.03% | -13.48% | -1.82% | 66.91% | 72.53% |
| Normalized Diluted EPS | 18.29% | -14.78% | -5.51% | 65.77% | 71.29% |
| Average Basic Shares Outstanding | 127.42% | 2.87% | 2.80% | 215.72% | 161.69% |
| Average Diluted Shares Outstanding | 127.42% | 2.87% | 2.80% | 215.72% | 161.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |